Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$216.45 USD

216.45
856,418

+3.80 (1.79%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $216.00 -0.45 (-0.21%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (59 out of 251)

Industry: Internet - Software

Zacks News

Here's Why You Should Invest in PRA Health (PRAH) Stock Now

The CRO industry's bullish prospects currently make PRA Health (PRAH) a promising investment pick.

    TransEnterix's MST Medical Buyout to Boost Senhance Platform

    TransEnterix (TRXC) acquires Israel-based MST Medical, which will boost surgeons' effectiveness and make procedures quick and error-free.

      Veeva (VEEV) Up 16.1% Since Last Earnings Report: Can It Continue?

      Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

        Here's Why You Should Buy Intuitive Surgical (ISRG) Now

        Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.

          Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

          Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

            Abbott Banks on New Approvals and Buyouts, Competition Rife

            Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.

              Sreyoshi Mukherjee headshot

              3 Top Stocks From the Booming US Medical Products Industry

              The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

                Cerner Integrated Platform Implemented by Spectrum Health

                Spectrum Health selects Cerner's (CERN) Cerner Integrated Platform to treat psychological disorders.

                  Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now

                  AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.

                    Veeva's Vault CDMS to Unify Clinical Data in Single Platform

                    Veeva's (VEEV) cloud-based applications' market prospects bright.

                      Here's Why You Should Invest in Masimo (MASI) Right Now

                      A raised guidance for 2018 and positive developments make Masimo (MASI) a lucrative choice for investors.

                        Is Veeva Systems (VEEV) Outperforming Other Computer and Technology Stocks This Year?

                        Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?

                          Veeva Gains as MD&D Companies Pick Its Cloud-Based Services

                          Veeva's (VEEV) focus on cloud-based services is likely to open up substantial opportunities for the company.

                            Nabaparna Bhattacharya headshot

                            3 Cloud-Powered MedTech Stocks to Buy Right Now

                            Here we take a look at three MedTech companies that are likely to make big business banking on cloud technologies.

                              Earnings Estimates Moving Higher for Veeva Systems (VEEV): Time to Buy?

                              Veeva Systems (VEEV) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

                                Here's Why You Should Invest in Veeva (VEEV) Stock Right Now

                                Strong fundamentals and a solid Q2 aid Veeva (VEEV).

                                  Is Veeva Systems (VEEV) Stock Outpacing Its Computer and Technology Peers This Year?

                                  Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?

                                    Time to Focus on Veeva Systems (VEEV) for Strong Earnings Growth Potential

                                    Veeva Systems (VEEV) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

                                      Veeva (VEEV) Hits 52-Week High, Can the Run Continue?

                                      Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

                                        Veeva Systems (VEEV) Q2 Earnings & Revenues Beat Estimates

                                        Veeva Systems (VEEV) gains from its flagship Vault platform. Also, expanding margins are an added positive for the company.

                                          Veeva Systems (VEEV) Q2 Earnings and Revenues Top Estimates

                                          Veeva (VEEV) delivered earnings and revenue surprises of 14.71% and 2.92%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?

                                            Can Segmental Growth Boost Veeva Systems' (VEEV) Q2 Earnings?

                                            Veeva Systems' (VEEV) Q2 results to benefit from growing demand for cloud-based and vault applications, new product launches, industry focus approach along with international expansion.

                                              Veeva Systems' Development Cloud Platform Picked by Idorsia

                                              Switzerland's Idorsia implements Veeva Systems' (VEEV) Development Cloud. Veeva Systems gains foothold in Europe.

                                                Why is Veeva Systems (VEEV) Up 8.3% Since Its Last Earnings Report?

                                                Veeva Systems (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                                  The Zacks Analyst Blog Highlights: 3M, Altria, Stryker, UnitedHealth and Veeva

                                                  The Zacks Analyst Blog Highlights: 3M, Altria, Stryker, UnitedHealth and Veeva